Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lupus Erythematosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03030118
What this trial is testing

Study of Anti-Malarials in Incomplete Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Milton S. Hershey Medical Center 187
Early research (Phase 1)Looking for participantsNCT07215663
What this trial is testing

Clinical Study of Cizutamig in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Candid Therapeutics 47
Not applicableStudy completedNCT04580108
What this trial is testing

Highly Sensitive Serum Cardiac Troponin T and Cardiovascular Events in Patients With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Assistance Publique - Hôpitaux de Paris 446
Early research (Phase 1)Active Not RecruitingNCT06799520
What this trial is testing

Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s)

Who this might be right for
Systemic Lupus Erythematosus (SLE)Alopecia Areata (AA)Immune-mediated Focal Segmental Glomerulosclerosis (FSGS)
Otsuka Pharmaceutical Development & Commercialization, Inc. 30
Not applicableUnknownNCT06294483
What this trial is testing

Comparison Between Early-onset and Late-onset Patients With Systemic Lupus Erythematosus.

Who this might be right for
Systemic Lupus Erythematosus
Sohag University 100
Early research (Phase 1)Looking for participantsNCT06737380
What this trial is testing

UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients

Who this might be right for
SLELupusSystemic Lupus Erthematosus+2 more
LiveKidney.Bio 10
Not applicableStudy completedNCT05115370
What this trial is testing

Vaccination Perception in Inflammatory Conditions - Flu, Pneumonia and COVID-19

Who this might be right for
Inflammatory DiseaseRheumatoid ArthritisPsoriatic Arthritis+5 more
University of Nottingham 20
Not applicableStudy completedNCT05747651
What this trial is testing

3TR (Taxonomy, Treatment, Targets and Remission) Systemic Lupus Erythematosus Study Protocol 2

Who this might be right for
Systemic Lupus Erythematosus (SLE)
University Hospital, Brest 6
Large-scale testing (Phase 3)Study completedNCT01639339
What this trial is testing

Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Human Genome Sciences Inc., a GSK Company 448
Early research (Phase 1)Looking for participantsNCT07491900
What this trial is testing

HB2198 in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erthematosus (SLE)Lupus Nephritis (LN)Extra-renal Lupus (ERL)
Hinge Bio 30
Testing effectiveness (Phase 2)Ended earlyNCT01777256
What this trial is testing

An Adaptive Phase II Study to Evaluate the Efficacy, Pharmacodynamics, Safety and Tolerability of GSK2586184

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 51
Not applicableUnknownNCT06210295
What this trial is testing

Anemia in Systemic Lupus Erythematosus Specially Refractory Type

Who this might be right for
Refractory Anemia in Systemic Lupus Erythematosis
Assiut University 67
Not applicableStudy completedNCT03206359
What this trial is testing

GADD34 and Type I IFN Response Genes in SLE

Who this might be right for
Systemic Lupus Erythematosus
University Hospital, Grenoble 90
Testing effectiveness (Phase 2)Study completedNCT01058343
What this trial is testing

Safety of IFNa Kinoid in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Neovacs 28
Early research (Phase 1)Looking for participantsNCT07318259
What this trial is testing

Study of Ultra-Fast BCMA/CD70 CAR-T Therapy for Refractory SLE

Who this might be right for
Systemic Lupus Erythematosus
Chongqing Precision Biotech Co., Ltd 18
Not applicableStudy completedNCT02364908
What this trial is testing

Prospective Evaluation of Decision and Compliance With Antimalarials in Patients With Systemic Lupus

Who this might be right for
Systemic Lupus Erythematosus
University Hospital, Lille 158
Testing effectiveness (Phase 2)Active Not RecruitingNCT05798117
What this trial is testing

An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Novartis Pharmaceuticals 21
Not applicableStudy completedNCT02350491
What this trial is testing

Study During Pregnancy of Expression of miRNAs in RA or SLE

Who this might be right for
Rheumatoid ArthritisSystemic Lupus Erythematosus
University Hospital, Strasbourg, France 50
Early research (Phase 1)Ended earlyNCT00684255
What this trial is testing

Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc)

Who this might be right for
Systemic Lupus ErythematosusSystemic Sclerosis
New York Medical College 1
Early research (Phase 1)Study completedNCT01686555
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-199 in Female Patients With Systemic Lupus Erythematosus (SLE)

Who this might be right for
Lupus Erythematosus
AbbVie (prior sponsor, Abbott) 97
Next Page